Bulandres, Marites .
HRN: 20-88-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CEFUROXIME 500MG (TAB)
02/19/2024
02/26/2024
ORAL
500mg
BID
S/P Pelvic Laparotomy
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes